Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2022) 85 OC9.3 | DOI: 10.1530/endoabs.85.OC9.3

BSPED2022 Oral Communications Oral Communications 9 (8 abstracts)

Diabetes and obesity in down syndrome across the lifespan: a retrospective cohort study using UK electronic health records

Aisha Aslam 1 , Asaad Baksh 2,3 , Sarah Pape 2,3,4 , Go-DS21 Consortium 5 , Andre Strydom 2,3,4 , Martin Gulliford 2,6 & Li Chan 1


1Centre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom; 2Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, United Kingdom; 3The LonDowns Consortium, London, United Kingdom; 4South London and Maudsley NHS Foundation Trust, London, United Kingdom; 5Go-DS21 Consortium, Illkirch, France; 6Department of Basic and Clinical Neuroscience, King’s College London, Institute of Psychiatry Psychology and Neuroscience, London, United Kingdom


Background: Down Syndrome (DS) is the commonest form of chromosomal trisomy. Genetic factors in DS may increase the risk for diabetes. Obesity and type 2 diabetes mellitus (T2DM) rates have increased in the general populationbut it is not known whether this similarly affected people with DS.

Objective: To determine whether DS is associated with increased incidence of diabetes and the relationship with obesity across the lifespan compared to controls.

Methods: Matched population-based cohort study (UK Clinical Practice Research Datalink, 1990-2020). DS patients were identified using diagnostic codes for DS or Trisomy 21; up to 4 matched controls for each DS case was selected.

Results: 9,917 DS and 38,266 control patients were analysed. Diabetes rates were higher in DS individuals (incidence rate ratio 3.68; 95% CI 2.43 – 5.57; p<0.0001) and peaked at a younger age with over four times higher incidence per 1,000 patient years in children with DS aged 5-14 years old (1.55; 95% CI 0.95 - 2.39) compared to controls (0.38; 95% CI 0.25 – 0.57). There was over six times increased incidence of T1DM in patients with DS aged 15-24 years (1.13; 95% CI 0.62 - 1.90) compared to controls (0.18; 95% CI 0.09 - 0.33). T2DM rates were higher in DS compared to controls at age groups 5 years up to 34 years with over 10 times increased incidence in children aged 5-14 years with DS (0.62; 95% CI 0.27 - 1.22) compared to controls (0.06; 95% CI 0.02 - 0.16). In DS, peak mean BMI (kg/m2) was higher and at younger age (male=31.2 at 31 years; female=32.1 at 43 years) compared to controls (males=29.5 at 54 years; females 29.2 at 51 years); obesity was associated with an increased incidence of T2DM.

Conclusions: At younger ages, the incidence of diabetes in DS patients is up to four times that of controls. Peak mean BMI is higher and established earlier in DS, contributing to T2DM risk. Further investigation into the relationship between obesity and diabetes in DS is required to inform treatment and prevention measures.

Volume 85

49th Annual Meeting of the British Society for Paediatric Endocrinology and Diabetes

Belfast, Ireland
02 Nov 2022 - 04 Nov 2022

British Society for Paediatric Endocrinology and Diabetes 

Browse other volumes

Article tools

My recent searches

No recent searches.